5P Hormonal biomarkers can improve prediction of response to hormonal therapy in advanced and recurrent endometrial cancer: Results of the PROMOTE-R study

Autor:	A. van de Stolpe, H. J. van Beekhuizen, A. Van Ginkel, L. Van Lonckhuijzen, Kristina Lindemann, J.M.A. Pijnenborg, David Forsse, Camilla Krakstad, Johan Bulten, R. Yigit, Márcia Alves De Inda, Vít Weinberger, D. Boll, Roy I. Lalisang, Khadra Galaal, E. Witteveen, WJ van Weelden, Hmj Werner, Hans Trum, Andrea Romano
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine Hormonal therapy Hematology business Recurrent Endometrial Cancer Hormone
Zdroj:	Annals of Oncology. 31:S1218
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::626fdcb7108857838701b8e785ab4a76 https://doi.org/10.1016/j.annonc.2020.08.2164 Zobrazit plný text záznamu